Showing results (101-110 of 372) with videos related to
Sort By:
Pageof 38
Pediatric Transplantation|October 7, 2014
Interleukin-2 receptor antagonists for pediatric liver transplant recipients: a systematic review and meta-analysis of controlled studiesNicola D Crins, Christian Röver, Armin D Goralczyk, et al.Statistics in Medicine|August 21, 2020
Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trialsTobias Mütze, Susanna Salem, Norbert Benda, et al.Drugs & Aging|June 10, 2025
Real-World Harm Reduction of Metformin Plus DPP4 Inhibitors versus Metformin Plus Sulfonylureas in Older Adults: A Target Trial Emulation Using German Claims DataPaula Starke, Petra Thürmann, Thomas Grobe, et al.Statistical Methods in Medical Research|April 9, 2024
Methods for non-proportional hazards in clinical trials: A systematic reviewMaximilian Bardo, Cynthia Huber, Norbert Benda, et al.European Heart Journal. Digital Health|January 30, 2023
Applications of artificial intelligence/machine learning approaches in cardiovascular medicine: a systematic review with recommendationsSarah Friedrich, Stefan Groß, Inke R König, et al.BMC Medical Research Methodology|July 14, 2016
EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchersRebecca Sudlow, Janice Branson, Tim Friede, et al.Biometrical Journal. Biometrische Zeitschrift|November 26, 2016
Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptationsCornelia U Kunz, Nigel Stallard, Nicholas Parsons, et al.Statistics in Medicine|June 27, 2015
Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trialNigel Stallard, Cornelia Ursula Kunz, Susan Todd, et al.Neurology|September 28, 2005
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosisDavid J Rog, Turo J Nurmikko, Tim Friede, et al.Journal of Biopharmaceutical Statistics|April 5, 2014
A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpointsCornelia Ursula Kunz, Tim Friede, Nicholas Parsons, et al.Pageof 38